Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of pancreatic cancer [0.03%]
纳脂体制备的伊立替康联合氟尿嘧啶和亚叶酸钙治疗胰腺罕见组织学类型癌的有效性和安全性
Tomonao Taira,Tomoyuki Satake,Go Igarashi et al.
Tomonao Taira et al.
Background: Pancreatic cancers other than pancreatic ductal adenocarcinoma (PDAC) are rare and heterogeneous, accounting for fewer than 5%-7% of all pancreatic cancers. These include acinar cell carcinoma, undifferentiate...
Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3) [0.03%]
日本女性乳腺癌、宫颈癌和卵巢癌患者五年净生存率(CONCORD-3)的流行情况(2000~14年)
Kaname Watanabe,Veronica Di Carlo,Hiromi Sugiyama et al.
Kaname Watanabe et al.
Background: Breast, cervical and ovarian cancers significantly affect young and middle-aged women, both physically and socially. However, relevant comprehensive stratified analyses are limited. Using Japanese data from CO...
Trends in survival for adult patients with hematopoietic malignancies in Japan, 2000-14 (CONCORD-3) [0.03%]
日本成人血液系统恶性肿瘤患者的生存趋势(CONCORD-3),2000~2014年
Isao Yoshida,Veronica Di Carlo,Melissa Matz et al.
Isao Yoshida et al.
Background: We aimed at estimating trends in 5-year net survival for myeloid and lymphoid malignancies, by age group and morphological subtype, using data on patients diagnosed during 2000-2014 and registered by 16 Japane...
Trends in net survival for cancers of the liver and pancreas in Japan, 2000-14 (CONCORD-3) [0.03%]
日本肝癌和胰腺癌净生存率变化(2000年至2014年)(来自“全球癌症生存统计数据库”第三期)
Marisa Nishio,Melissa Matz,Hiromi Sugiyama et al.
Marisa Nishio et al.
Background: Pancreatic and liver cancers are the 6th and 7th most common cancers in Japan and are major contributors to cancer mortality. Methods: ...
Trends in survival for patients with esophageal cancer in Japan, 2000-14 (CONCORD-3) [0.03%]
2000~2014年日本食管癌患者的生存趋势(康科德-3)
Tomohiro Matsuda,Veronica Di Carlo,Melissa Matz et al.
Tomohiro Matsuda et al.
Background: We assessed trends and international comparisons of net survival for patients with esophageal cancer using data from Japanese regional population-based cancer registries participating in the CONCORD-3 study. ...
Trends in net survival for prostate cancer in Japan, 2000-14 (CONCORD-3) [0.03%]
日本前列腺癌净生存率变化(CONCORD-3):2000至2014年
Rina Tanaka,Melissa Matz,Hiromi Sugiyama et al.
Rina Tanaka et al.
Background: We aimed at assessing 15-year trends in 5-year net survival for men diagnosed with prostate cancer during 2000-2014 and registered by 16 Japanese regional population-based cancer registries included in the CON...
Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000-14 (CONCORD-3) [0.03%]
日本儿童脑肿瘤、急性淋巴细胞白血病和淋巴瘤生存率(康科德-3)的流行趋势(2000~2014年)
Kayo Nakata,Veronica Di Carlo,Melissa Matz et al.
Kayo Nakata et al.
Background: We assessed survival trends for children with brain tumors, acute lymphoblastic leukemia (ALL), and lymphomas from 16 Japanese regional population-based cancer registries participating in CONCORD-3. ...
Trends in net survival for cancers of the colon and rectum in Japan, 2000-14 (CONCORD-3) [0.03%]
日本结肠和直肠癌标准化生存率(2000~2014)(CONCORD-3)
Izumi Oki,Melissa Matz,Hiromi Sugiyama et al.
Izumi Oki et al.
Background: We aimed to assess 15-year trends in the 5-year net survival for patients with colon or rectal cancer from 2000 to 2014 and registered in the 16 Japanese regional population-based cancer registries included in...
Trends in survival for patients with lung cancer in Japan, 2000-14 (CONCORD-3) [0.03%]
2000~2014年日本肺癌患者的生存趋势(CONCORD-3)
Isao Oze,Melissa Matz,Hiromi Sugiyama et al.
Isao Oze et al.
Lung cancer is the leading cause of cancer death worldwide. To aid the development of lung cancer control strategies, we analyzed trends in lung cancer survival using data from 16 population-based cancer registries in Japan that participate...
Trends in survival for cancer patients diagnosed during 2000-14 in Japan: detailed analysis of individual data from population-based cancer registries (CONCORD-3) [0.03%]
2000至2014年日本癌症患者生存率的流行趋势:来自基于人口的癌症登记机构个体数据的详细分析(CONCORD-3)
Hiromi Sugiyama,Veronica Di Carlo,Tomohiro Matsuda et al.
Hiromi Sugiyama et al.